https://www.selleckchem.com/products/AZD0530.html
The quality of life of patients was assessed using the Dermatology Life Quality Index. Of the 14 enrolled patients, 11 completed the trial. The protocol-specified grade of acneiform eruptions from baseline to week 8 improved from 2.0 to 1.0 (P less then 0.01). The dermatology life quality index score from baseline to week 8 improved from 3.0 to 1.0 point (P less then 0.01). No patient experienced severe adverse events. Overall, topical benzoyl peroxide may be effective for treating and managing prolonged acneiform eruptions induced by e
Like
Comment
Share
